Iovance Biotherapeutics Inc. buy Truist Financial Co.
Start price
27.12.23
/
50%
€6.20
Target price
27.12.24
€15.35
Performance (%)
12.30%
End price
28.12.24
€6.96
Summary
This prediction ended on 28.12.24 with a price of €6.96. The BUY prediction by Truist_Financial_Co_ finished with a performance of 12.30%. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 6.247% | 6.247% | 8.587% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $17.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.84
03.03.25
03.03.25
€14.29
03.03.26
03.03.26
-17.77%
04.03.26
04.03.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.09
15.09.23
15.09.23
€15.92
15.09.24
15.09.24
76.82%
16.09.24
16.09.24